The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Astellas Pharma; Bayer; Janssen
Consulting or Advisory Role - Bayer; Janssen
Speakers' Bureau - Bayer; Janssen
Research Funding - Bayer
Analysis of overall survival by number of radium-223 injections received in an international expanded access program (iEAP).
 
Fred Saad
Honoraria - Abbvie; Amgen; Astellas Pharma; Bayer; Janssen Oncology; Novartis; Sanofi
Consulting or Advisory Role - Abbvie; Amgen; Astellas Pharma; Bavarian Nordic; Janssen Oncology; Millennium; Novartis; Sanofi
Research Funding - Amgen (Inst); Astellas Pharma (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Janssen Oncology (Inst); Oncogenex (Inst); Sanofi (Inst)
 
Daniel Keizman
Honoraria - Bayer; Janssen Oncology; Pfizer; Sanofi
Consulting or Advisory Role - Bayer; Janssen Oncology; Pfizer; Sanofi
Travel, Accommodations, Expenses - Bayer; Janssen Oncology; Pfizer; Sanofi
 
Joe M. O'Sullivan
No Relationships to Disclose
 
Joan Carles
Consulting or Advisory Role - Amgen; Astellas Pharma; Bayer; Bristol-Myers Squibb; Johnson & Johnson; Pfizer
Speakers' Bureau - Bayer
 
Manfred Wirth
Consulting or Advisory Role - Amgen; Apogepha; Astellas Pharma; Bayer; Janssen-Cilag
Expert Testimony - Amgen; Apogepha; Astellas Pharma; Bayer; Janssen-Cilag
Travel, Accommodations, Expenses - Amgen; Apogepha; Astellas Pharma; Bayer; Janssen-Cilag
 
Silke Gillessen
Consulting or Advisory Role - Astellas Pharma; Bayer; Curevac; Dendreon; Janssen-Cilag; Millennium; Novartis; Orion; pfizer; Sanofi
Patents, Royalties, Other Intellectual Property - Method for biomarker (WO 3752009138392 A1)
 
Camilla Thellenberg-Karlsson
Consulting or Advisory Role - Bayer; Sanofi
 
Kurt Miller
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Ferring; Janssen; Merck Sharp & Dohme; Novartis; Roche
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Ferring; Janssen; Merck Sharp & Dohme; Novartis; Roche; Sotio
Research Funding - Janssen; Novartis
 
Marcello Tucci
Consulting or Advisory Role - Astellas Pharma; Bayer; Janssen; Sanofi
 
Giovanni Paganelli
Honoraria - Bayer
Consulting or Advisory Role - Bayer
Speakers' Bureau - Bayer
 
Giuseppe Procopio
Honoraria - Astellas Pharma; Janssen
Consulting or Advisory Role - Bayer; Janssen; Novartis
 
Jeremy Gratt
Consulting or Advisory Role - Bayer
 
Monica Seger
Employment - Bayer
Stock and Other Ownership Interests - Bayer
Patents, Royalties, Other Intellectual Property - Royalties fr/late husband's patents (I)
 
Sten Nilsson
Consulting or Advisory Role - Bayer; Roche
 
Daniel Heinrich
Honoraria - Astellas Pharma; Bayer; Janssen-Cilag
Consulting or Advisory Role - Amgen; Astellas Pharma; Bayer
Travel, Accommodations, Expenses - Bayer